Download PDF
Arzneimittelforschung 2008; 58(6): 277-282
DOI: 10.1055/s-0031-1296507
CNS-active Drugs · Hypnotics · Psychotropics · Sedatives
Editio Cantor Verlag Aulendorf (Germany)

Effect of Ibudilast on Non-specific Symptoms in Patients with Chronic Cerebral Ischemia

Analysis of cerebral blood flow
Nobuhiro Inoue
1   Department of Neurosurgery, Kumamoto Neurosurgical Hospital, Kumamoto, Japan
,
Mikio Harada
1   Department of Neurosurgery, Kumamoto Neurosurgical Hospital, Kumamoto, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
15 December 2011 (online)

    Permissions and Reprints

Abstract

Background and purpose:

Many patients with chronic cerebrovascular disease complain that dizziness and depression negatively affect their daily lives. In these patients, ibudilast (CAS 50847-11-5) reportedly ameliorated dizziness. The efficacy of ibudilast was investigated and its effect on the cerebral blood flow (CBF) was recorded.

Methods:

The study population consisted of 11 patients (male and female) with chronic cerebrovascular disease complaining of dizziness or depression. They received 30 mg of ibudilast orally per day. The grade of vertigo and depression at entry into this study and 2 and 6 months after the start of therapy was recorded. Their depressive state was scored with the Japan Stroke Scale-Depression Scale (JSS-D) and their cerebral blood flow (CBF) was measured before and approximately 3 months after the start of ibudilast therapy.

Results:

At 6 months after the start of ibudilast therapy, all patients reported the resolution of dizziness; of the 6 patients with depression at entry, all experienced significant improvement. At 3 months, the CBF was significantly increased in the right frontal (p = 0.019) and occipital cortex (p = 0.004) with no significant changes in the cerebellar folia, subcortical gray matter (striatum and thalamus), and other cerebral cortices in the right cerebral hemisphere. There were no significant CBF changes in any areas of the left cerebral hemisphere.

Conclusion:

In patients treated with ibudilast, the amelioration of dizziness and depression was accompanied by a CBF increase in the right frontal and occipital cortices. These findings suggest that the right frontal and occipital cortices may be related to their dizziness and depression.

Key words

CAS 50847-11-5 - Depression, post-stroke - Ibudilast, cerebral ischemia, clinical study - Ketas® - Phosphodiesterase inhibitors - Vertigo
 

  • References

  • 1 Leigh RJ, Zee DS. The Neurology of Eye Movements. New York: Oxford University Press; 1999
    Google Scholar
  • 2 Baloh RW. The dizzy patient. Postgrad Med. 1999; 105: 161-164
    PubMedGoogle Scholar
  • 3 Tusa RJ. Dizziness. Med Clin North Am. 2003; 87: 609-641 vii
    CrossrefPubMedGoogle Scholar
  • 4 Brandt T, Strupp M. General vestibular testing. Clin Neurophysiol. 2005; 116: 406-426
    CrossrefPubMedGoogle Scholar
  • 5 Burt CW, Schapper SM. Ambulatory care visits to physician offices, hospital out-patient departments, and emergency departments: United States, 1999–2000. Vital Health Stat. 2004; 13: 1-70
    PubMedGoogle Scholar
  • 6 Kerber KA, Brown DL, Lisabeth LD, Smith MA, Morgenstern LB. Stroke among patients with dizziness, vertigo, and imbalance in the emergency department. A population-based study. Stroke. 2006; 37: 2484-2487
    CrossrefPubMedGoogle Scholar
  • 7 Fujishima M, Yao H, Terashi A, Tagawa K, Matsumoto M, Hara H et al. Deep white matter lesions on MRI, and not silent brain infarcts are related to headache and dizziness of nonspecific cause in non-stroke Japanese subjects. Intern Med. 2000; 39: 727-731
    CrossrefPubMedGoogle Scholar
  • 8 Robinson RG, Szetela B. Mood change following left hemisphere brain injury. Ann Neurol. 1981; 9: 447-453
    CrossrefPubMedGoogle Scholar
  • 9 Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood disorders in stroke patients: Importance of location. Brain. 1984; 107: 81-93
    CrossrefPubMedGoogle Scholar
  • 10 Robinson RG. The clinical neuropsychiatry of stroke. Cambridge: Cambridge University Press; 1988
    Google Scholar
  • 11 Kishi Y, Ohta S, Sakita S, Ashikaga T, Isobe M. Ibudilast: A nonselective PDE inhibitor with multiple actions on blood cells and the vascular wall. Cardiovasc Drug Rev. 2001; 19: 215-225
    PubMedGoogle Scholar
  • 12 Renau TE. The potential of phosphodiesterase 4 inhibitors for the treatment of depression: Opportunities and challenges. Curr Opin Invest Drugs. 2004; 5: 34-39
    PubMedGoogle Scholar
  • 13 Fukuyama H, Kimura J, Yamaguchi S, Ymauchi H, Ogawa M, Doi T et al. Pharmacological effects of ibudilast on cerebral circulation: A PET study. Neurol Res. 1993; 15: 169-173
    PubMedGoogle Scholar
  • 14 Yamashita T, Urakawa M, Hayashi M, Nakano S, Kashiwagi S, Ishihara H et al. The effect of ibudilast on local cerebral blood flow in patients with chronic ischemic cerebrovascu-lar lesions. Prog Med. 1993; 13: 59-66 (In Japanese with English abstract)
    PubMedGoogle Scholar
  • 15 Shinohara Y, Kusunoki T, Nakashima M. Clinical efficacy of Ibudilast on vertigo and dizziness observed in patients with cerebral infarction in the chronic stage–a double-blind, randomized, placebo-controlled trial with a run-in period. Neurol Ther. 2002; 19: 177-187 (In Japanese with English abstract)
    PubMedGoogle Scholar
  • 16 Japan Stroke Society. Japan Stroke Scale (Emotional Disturbance Scale) <JSS-D · JSS-E>.. Jpn J Stroke. 2003; 25: 206-214 (In Japanese)
    CrossrefPubMedGoogle Scholar
  • 17 Kaji Y, Hirata K, Ebata A. Post-stroke depression (PSD) at the subacute stage after stroke: A study on an appropriate and easy evaluation strategy for its diagnosis. Jpn J Stroke. 2004; 26: 441-448 (In Japanese with English abstract)
    CrossrefPubMedGoogle Scholar
  • 18 Kaji Y, Hirata K. Depression after stroke. Nippon Rinsho. 2006; 64: 445-450 (In Japanese)
    PubMedGoogle Scholar
  • 19 Yonas H, Darby JM, Marks EC, Durham SR, Maxwell C. CBF measured by Xe/CT–approach to analysis and normal values. J Cereb Blood Flow Metab. 1991; 11: 716-725
    CrossrefPubMedGoogle Scholar
  • 20 Dean BL, Hodak JA, Drayer BP, Lee C, Graham TW, Conrad GR. Cerebral Blood Flow Measurement with Stable Xenon-Enhanced Computed Tomography. Yonas H. editor New York: Raven Press; 1992. p 156-161
    Google Scholar
  • 21 Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissue. Pharmacol Rev. 1951; 3: 1-41
    PubMedGoogle Scholar
  • 22 Arai M, Higuchi A, Itoh T, Mochimatu Y, Hayashi H, Itoh K. A comparison between peripheral and central origin in elderly patients with vestibular vertigo by using magnetic resonance angiography and single photon emission computed tomography using I-123 iodoamphetamine. Equilibrium Res. 2001; 60: 169-176 (In Japanese with English abstract)
    CrossrefPubMedGoogle Scholar
  • 23 Koyuncu M, Elhami AR, Akan H, Sahin M, Basoglu T, Simsek M. Investigation of the vertebrobasilar arterial system in vertigo by vestibulocochlear test, SPECT and angiography. Auris Nasus Larynx. 2001; 28: 23-28
    CrossrefPubMedGoogle Scholar
  • 24 Bench CJ, Friston KJ, Brown RG, Frackowiak RSJ, Dolan RJ. Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions. Psychol Med. 1993; 23: 579-590
    CrossrefPubMedGoogle Scholar
  • 25 Rubin E, Sackeim HA, Prohovnik I, Moeller JR, Schnur DB, Mukherjee S. Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression. Psychiat Res Neuroimaging. 1995; 61: 1-10
    PubMedGoogle Scholar
  • 26 Okada K, Kobayashi S, Yamagata S, Takahashi K, Yamaguchi S. Post-stroke apathy and regional cerebral blood flow. Stroke. 1997; 28: 2437-2441
    CrossrefPubMedGoogle Scholar
  • 27 Kimura M, Shimoda K, Mizumura S, Tateno A, Tatsuma F, Mori T et al. Regional cerebral blood flow in vascular depression assessed by 123 I-IMP SPECT. J Nippon Med Sch. 2003; 70: 321-326
    CrossrefPubMedGoogle Scholar
  • 28 Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE et al. Reduction of prefrontal cortex metabolism common to three types of depression. Arch Gen Psychiatry. 1990; 46: 243-250
    PubMedGoogle Scholar
  • 29 Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attat-Levy D et al. Left prefrontal glucose hypometabolism in the depressed state: A confirmation. Am J Psychiatry. 1990; 147: 1313-1317
    PubMedGoogle Scholar
  • 30 Takano T, Kimura K, Nakamura M, Fukunaga R, Kusunoki M, Etani H et al. Effect of small deep hemispheric infarction on the ipsilateral cortical blood flow in man. Stroke. 1985; 16: 64-69
    CrossrefPubMedGoogle Scholar
  • 31 Yamaguchi S, Kobayashi S, Koide H, Tsunematsu T. Longitudinal study of regional cerebral blood flow changes in depression after stroke. Stroke. 1992; 23: 1716-1722
    CrossrefPubMedGoogle Scholar
  • 32 Mayberg HS, Robinson RG, Wong DF, Parikh RM, Bolduc PL, Starkstein SE et al. PET imaging of cortical S2 serotonin receptors after stroke: Lateralized changes and relationship to depression.. Am J Psychiatry. 1988; 145: 937-943
    PubMedGoogle Scholar
  • 33 Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry. 1989; 154: 170-182
    CrossrefPubMedGoogle Scholar
  • 34 Brophy VH, Ro SK, Rhees BK, Lui LY, Lee JM, Umblas N et al. Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a US population stratified by hypertension status.. Stroke. 2006; 37: 1385-1390
    CrossrefPubMedGoogle Scholar
  • 35 Worrall B, Mychaleckyj JC. PDE4D and stroke. A real advance or a case of the emperor’s new clothes?. Stroke. 2006; 37: 1955-1957
    CrossrefPubMedGoogle Scholar